ZVRA Zevra Therapeutics, Inc.
Healthcare$10.32+2.89%ClosedMarket Cap: $610.1M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$25.50
Target (Median)
$25.50
Target Range
$25.00 - $26.00
Upside from current price: 147.1%
Rating Distribution
2 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Guggenheim | maintain | Buy | Buy |
| 2025-11-06 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-11-06 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-08-13 | JMP Securities | maintain | Market Outperform | Market Outperform |
| 2025-07-10 | Cantor Fitzgerald | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.40 | $215.3M | 5 |
| Sun Dec 31 | $2.43 | $302.6M | 7 |
| Mon Dec 31 | $3.02 | $360.7M | 2 |
| Tue Dec 31 | $3.39 | $409.7M | 5 |